Henry Rosevear, MD, talks about how he and his practice are coping with the COVID-19 pandemic.
Henry Rosevear, MD, Urology Times® Clinical Practice Board member and blogger, has written thoughtfully and eloquently about the COVID-19 pandemic in recent blog posts for UrologyTimes.com. Urology Times® spoke to him on April 7 about how he and his practice are coping with the present situation. Also see: COVID-19 and urology: What you can do How ‘elective’ surgery is defined during the COVID-19 crisis Telemedicine in urology: A crash course during the COVID-19 pandemic
Prostate cancer genomic tests show prognostic value for progression, therapy benefit
April 22nd 2024"This preplanned ENACT trial biomarker analysis demonstrates the value of the Decipher score, AR-A score, and PAM50 genomic classifiers in identifying patients undergoing AS who are most likely to benefit from enzalutamide treatment," wrote the authors.